Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 116, Issue 1, 2013, Pages 55-60

  Lim, Yoojoo ^a   Keam, Bhumsuk ^a,b   Koh, Youngil ^a   Kim, Tae Min ^a,b   Lee, Se Hoon ^a,b   Hah, J Hun ^a,b   Kwon, Tack Kyun ^a   Kim, Dong Wan ^a,b   Wu, Hong Gyun ^a   Sung, Myung Whun ^a,b   Heo, Dae Seog ^a,b   Kim, Kwang Hyun ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CONFERENCE PAPER; FEMALE; HEAD AND NECK TUMOR; HUMAN; INDUCTION CHEMOTHERAPY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84879110471     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2013.02.007     Document Type: Conference Paper

References (23)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers; Version 1.2012. 2012:National Comprehensive Cancer Network. [Available at http://www.nccn.org/professionals/ physician-gls/pdf/head-and-neck.pdf ] MS10-MS27.
3. R.I. Haddad, G. Rabinowits, and R. Tishler The PARADIGM trial: a phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC) Proc Am Soc Clin Oncol 30 15-suppl 2012 5501
4. E.E.W. Cohen, T. Karrison, and M. Kocherginsky DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN) Proc Am Soc Clin Oncol 30 15-suppl 2012 5500
5. T.Y. Seiwert, J.K. Salama, and E.E. Vokes The chemoradiation paradigm in head and neck cancer Nat Clin Pract Oncol 4 2007 156 171
6. J.F. Ensley, J.R. Jacobs, and A. Weaver Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck Cancer 54 1984 811 814
7. Anon Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group N Engl J Med 324 1991 1685 1690
8. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
9. F.P. Worden, B. Kumar, and J.S. Lee Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number J Clin Oncol 26 2008 3138 3146
10. J.L. Lefebvre, D. Chevalier, B. Luboinski, A. Kirkpatrick, L. Collette, and T. Sahmoud Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 1996 890 899
11. Y. Koh, T.M. Kim, and Y.K. Jeon Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma Ann Oncol 20 2009 1414 1419
12. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
13. Y.H. Cho, S.H. Lee, and D.W. Kim Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer Head Neck 30 2008 346 350
14. P. Blanchard, B. Baujat, and V. Holostenco Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site Radiother Oncol 100 2011 33 40
15. T.K. Hoffmann, E. Sonkoly, and U. Hauser Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma Oral Oncol 44 2008 1100 1109
16. V. Patel, J.F. Ensley, J.S. Gutkind, and W.A. Yeudall Induction of apoptosis in head-and-neck squamous carcinoma cells by gamma-irradiation and bleomycin is p53-independent Int J Cancer 88 2000 737 743
17. Q. Sun, X. Zheng, L. Zhang, and J. Yu Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway Clin Cancer Res 17 2011 2361 2372
18. P.J. Schuler, S. Trellakis, and J. Greve In vitro chemosensitivity of head and neck cancer cell lines Eur J Med Res 15 2010 337 344
19. J.B. Vermorken, E. Remenar, and C. van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
20. M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
21. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
22. R. Hitt, A. Lopez-Pousa, and J. Martinez-Trufero Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 23 2005 8636 8645
23. J.H. Lorch, O. Goloubeva, and R.I. Haddad Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial Lancet Oncol 12 2011 153 159